(Q54316357)

27 May 2018

title

Activation of Syk in peripheral blood B cells in patients with rheumatoid arthritis: a potential target for abatacept therapy. (English)

1 reference

27 May 2018

1 reference

8

Kazuyoshi Saito

1 reference

27 May 2018

author name string

Shigeru Iwata

1

1 reference

27 May 2018

Shingo Nakayamada

2

1 reference

27 May 2018

Shunsuke Fukuyo

3

1 reference

27 May 2018

Satoshi Kubo

4

1 reference

27 May 2018

Naoki Yunoue

5

1 reference

27 May 2018

Sheau-Pey Wang

6

1 reference

27 May 2018

Maiko Yoshikawa

7

1 reference

27 May 2018

Yoshiya Tanaka

9

1 reference

27 May 2018

publication date

1 January 2015

1 reference

27 May 2018

published in

Arthritis & Rheumatology

1 reference

27 May 2018

volume

67

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

page(s)

63-73

1 reference

27 May 2018

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

cites work

1 reference

Tyrosine kinase inhibitors: a new approach for asthma

21 January 2018

1 reference

Downstream signals initiated in mast cells by Fc epsilon RI and other receptors

21 January 2018

1 reference

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk.

21 January 2018

1 reference

A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.

21 January 2018

1 reference

Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.

21 January 2018

1 reference

Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.

21 January 2018

1 reference

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients

21 January 2018

1 reference

Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.

21 January 2018

1 reference

Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis

21 January 2018

1 reference

Th17 cells and rheumatoid arthritis--from the standpoint of osteoclast differentiation--.

21 January 2018

1 reference

Follicular helper CD4 T cells (TFH)

21 January 2018

1 reference

Early Th1 cell differentiation is marked by a Tfh cell-like transition

21 January 2018

1 reference

Helper T cell diversity and plasticity

21 January 2018

1 reference

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

21 January 2018

1 reference

Tryptophan catabolism and regulation of adaptive immunity

21 January 2018

1 reference

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

21 January 2018

1 reference

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

21 January 2018

1 reference

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment

21 January 2018

1 reference

Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets

21 January 2018

1 reference

Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment

21 January 2018

1 reference

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition

21 January 2018

1 reference

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

21 January 2018

1 reference

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents

21 January 2018

1 reference

Treatment with TNFα blockers induces phenotypical and functional aberrations in peripheral B cells.

21 January 2018

1 reference

SLAM receptors and SAP influence lymphocyte interactions, development and function

21 January 2018

1 reference

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

21 January 2018

1 reference

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

21 January 2018

1 reference

Measurement of patient outcome in arthritis

21 January 2018

1 reference

Abatacept Limits Breach of Self-Tolerance in a Murine Model of Arthritis via Effects on the Generation of T Follicular Helper Cells

21 January 2018

1 reference

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis a

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.38895

1 reference

27 May 2018

1 reference

27 May 2018